Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 260

1.

Rates of immunization against pandemic and seasonal influenza in persons at high risk of severe influenza illness: a cross-sectional study among patients of the French Sentinelles general practitioners.

Privileggio L, Falchi A, Grisoni ML, Souty C, Turbelin C, Fonteneau L, Hanslik T, Kernéis S.

BMC Public Health. 2013 Mar 20;13:246. doi: 10.1186/1471-2458-13-246.

2.

Influenza vaccination coverage against seasonal and pandemic influenza and their determinants in France: a cross-sectional survey.

Vaux S, Van Cauteren D, Guthmann JP, Le Strat Y, Vaillant V, de Valk H, Lévy-Bruhl D.

BMC Public Health. 2011 Jan 12;11:30. doi: 10.1186/1471-2458-11-30.

3.

Barriers to pandemic influenza vaccination and uptake of seasonal influenza vaccine in the post-pandemic season in Germany.

Böhmer MM, Walter D, Falkenhorst G, Müters S, Krause G, Wichmann O.

BMC Public Health. 2012 Oct 31;12:938. doi: 10.1186/1471-2458-12-938.

4.

An analysis of national target groups for monovalent 2009 pandemic influenza vaccine and trivalent seasonal influenza vaccines in 2009-10 and 2010-11.

Ng S, Wu P, Nishiura H, Ip DK, Lee ES, Cowling BJ.

BMC Infect Dis. 2011 Aug 26;11:230. doi: 10.1186/1471-2334-11-230.

5.
6.

Vaccination coverage with seasonal and pandemic influenza vaccines in children in France, 2009-2010 season.

Weil-Olivier C, Lina B.

Vaccine. 2011 Sep 16;29(40):7075-9. doi: 10.1016/j.vaccine.2011.07.018. Epub 2011 Jul 21.

PMID:
21777639
7.

Factors associated with uptake of seasonal and pandemic influenza vaccine among clinical risk groups in the UK: an analysis using the General Practice Research Database.

Sammon CJ, McGrogan A, Snowball J, de Vries CS.

Vaccine. 2012 Mar 23;30(14):2483-9. doi: 10.1016/j.vaccine.2011.11.077. Epub 2011 Nov 29.

PMID:
22133511
8.

Pandemic influenza (A/H1N1) vaccine uptake among French private general practitioners: a cross sectional study in 2010.

Verger P, Flicoteaux R, Schwarzinger M, Sagaon-Teyssier L, Peretti-Watel P, Launay O, Sebbah R, Moatti JP.

PLoS One. 2012;7(8):e41837. doi: 10.1371/journal.pone.0041837. Epub 2012 Aug 3.

9.

Attitudes of the general public and general practitioners in five countries towards pandemic and seasonal influenza vaccines during season 2009/2010.

Blank PR, Bonnelye G, Ducastel A, Szucs TD.

PLoS One. 2012;7(10):e45450. doi: 10.1371/journal.pone.0045450. Epub 2012 Oct 11.

10.

Seasonal influenza vaccination coverage in France during two influenza seasons (2007 and 2008) and during a context of pandemic influenza A(H1N1) in 2009.

Tuppin P, Samson S, Weill A, Ricordeau P, Allemand H.

Vaccine. 2011 Jun 20;29(28):4632-7. doi: 10.1016/j.vaccine.2011.04.064. Epub 2011 May 6.

PMID:
21550376
11.

[Seasonal and pandemic influenza vaccination: coverage and attitude among private physicians in Germany].

Böhmer MM, Walter D, Ehrhardt J, Reiter S, Krause G, Wichmann O.

Gesundheitswesen. 2014 Jan;76(1):44-7. doi: 10.1055/s-0033-1343431. Epub 2013 Apr 30. German.

PMID:
23632821
12.

Field effectiveness of pandemic and 2009-2010 seasonal vaccines against 2009-2010 A(H1N1) influenza: estimations from surveillance data in France.

Pelat C, Falchi A, Carrat F, Mosnier A, Bonmarin I, Turbelin C, Vaux S, van der Werf S, Cohen JM, Lina B, Blanchon T, Hanslik T.

PLoS One. 2011 May 10;6(5):e19621. doi: 10.1371/journal.pone.0019621.

13.

Planning for the next influenza H1N1 season: a modelling study.

Carrat F, Pelat C, Levy-Bruhl D, Bonmarin I, Lapidus N.

BMC Infect Dis. 2010 Oct 21;10:301. doi: 10.1186/1471-2334-10-301.

14.

Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.

Ryan J, Zoellner Y, Gradl B, Palache B, Medema J.

Vaccine. 2006 Nov 17;24(47-48):6812-22. Epub 2006 Aug 4.

PMID:
17034909
15.

Factors associated with vaccination for hepatitis B, pertussis, seasonal and pandemic influenza among French general practitioners: a 2010 survey.

Pulcini C, Massin S, Launay O, Verger P.

Vaccine. 2013 Aug 20;31(37):3943-9. doi: 10.1016/j.vaccine.2013.06.039. Epub 2013 Jun 24.

PMID:
23806242
16.

[Pandemic influenza A (H1N1)v vaccination status and factors affecting vaccination: Ankara and Diyarbakır 2009 data from Turkey].

Ertek M, Sevencan F, Kalaycıoğlu H, Gözalan A, Simşek C, Culha G, Dorman V, Ozlü A, Arıkan F, Aktaş D, Akın L, Korukluoğlu G, Sevindi DF.

Mikrobiyol Bul. 2011 Oct;45(4):684-96. Turkish.

PMID:
22090299
17.

Hospitalization of influenza-like illness patients recommended by general practitioners in France between 1997 and 2010.

Pelat C, Lasserre A, Xavier A, Turbelin C, Blanchon T, Hanslik T.

Influenza Other Respir Viruses. 2013 Jan;7(1):74-84. doi: 10.1111/j.1750-2659.2012.00356.x. Epub 2012 Mar 22.

18.

Effectiveness of seasonal influenza vaccine against pandemic (H1N1) 2009 virus, Australia, 2010.

Fielding JE, Grant KA, Garcia K, Kelly HA.

Emerg Infect Dis. 2011 Jul;17(7):1181-7. doi: 10.3201/eid1707.101959.

19.

Estimates of pandemic influenza vaccine effectiveness in Europe, 2009-2010: results of Influenza Monitoring Vaccine Effectiveness in Europe (I-MOVE) multicentre case-control study.

Valenciano M, Kissling E, Cohen JM, Oroszi B, Barret AS, Rizzo C, Nunes B, Pitigoi D, Larrauri Cámara A, Mosnier A, Horvath JK, O'Donnell J, Bella A, Guiomar R, Lupulescu E, Savulescu C, Ciancio BC, Kramarz P, Moren A.

PLoS Med. 2011 Jan;8(1):e1000388. doi: 10.1371/journal.pmed.1000388. Epub 2011 Jan 11.

20.

Use of influenza A (H1N1) 2009 monovalent vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009.

National Center for Immunization and Respiratory Diseases, CDC; Centers for Disease Control and Prevention (CDC).

MMWR Recomm Rep. 2009 Aug 28;58(RR-10):1-8.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk